Ceftriaxone-induced symptomatic cholelithiasis in a child: case report and literature review

Mohammad I Smerat1, Balqis Shawer2, Bara M AbuIrayyeh2

  • 1Radiology Department, Ahli Hospital, Palestine.

PubMed

Insights

Ceftriaxone, a common antibiotic, can rarely cause gallbladder inflammation (cholecystitis) in children. Stopping the drug promptly resolved the condition in an 8-year-old patient.

Area of Science:

  • Pediatric Pharmacology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Ceftriaxone is a widely used third-generation cephalosporin antibiotic in pediatric care due to its broad spectrum and safety.
  • Uncommon adverse events, including cholecystitis (gallbladder inflammation), have been associated with ceftriaxone therapy.

Observation:

  • An 8-year-old female patient presented with right upper quadrant pain and nausea.
  • Imaging revealed gallstones and sludge, indicative of acute cholecystitis during ceftriaxone treatment.

Findings:

  • Discontinuation of ceftriaxone and supportive care led to the resolution of cholecystitis.
  • Gallbladder sludge and stones resolved completely following antibiotic withdrawal.

Implications:

  • Highlights the importance of recognizing ceftriaxone-induced cholecystitis in pediatric patients.
  • Early identification and cessation of the antibiotic can prevent surgical intervention and ensure successful treatment outcomes.

Related Concept Videos

Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
185
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
440
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
117
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
165
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157